Stock Movers: AstraZeneca, Puma, and Greggs Rally on Market News

Pharmaceutical Sector Gains

• 📈 AstraZeneca and other European pharmaceutical stocks saw gains following Pfizer's agreement with the US administration on drug pricing.
• 💡 Pfizer agreed to slash drug prices by up to 85% and sell directly to the American public, securing a three-year grace period from pharmaceutical tariffs.
• 🎯 This deal is seen by analysts as a potential bellwether for the sector, suggesting European companies might strike similar agreements to avoid tariffs.

Sportswear Demand Boost

• 👟 Puma and Adidas shares rose, influenced by Nike's better-than-expected sales report, particularly in the running and wholesale segments.
• 🚀 The market interpreted Nike's sales beat as a sign of consumer momentum in the sportswear sector, benefiting rivals.
• ⚠️ Puma, which has been struggling to appeal to shoppers, is expected to benefit from a more promising consumer environment.

Greggs Trading Update

• 🍞 Greggs shares experienced their biggest jump since 2021 after a positive trading update, indicating improved performance in August and September.
• 💰 The company reported easing cost inflation and confirmed expectations, providing relief to investors after a weaker July update.
• ⚠️ Despite the positive news, Greggs still faces challenges with a slowdown in store openings and some weakness in volumes.